Korro Bio, Inc. (KRRO)
NASDAQ • Healthcare
Last close at October 23, 2026 at 20:00 UTC
Metrics Over Time
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 11
in 17 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Korro Bio’s earnings topped expectations in the second fiscal quarter of 2026, based on preliminary results reported August 6, 2026, with EPS of -$1.07 topping the -$1.34 estimate by $0.27 and improving ~61% year over year from -$2.74. As an early-stage biotech focused on RNA editing programs, the quarter again reflected ongoing R&D-driven spending, with operating income of about -$20.1 million and net income of roughly -$18.9 million, a loss that narrowed ~27% from about -$25.8 million a year ago. Cash burn remained evident, with negative operating cash flow of roughly -$17.0 million. For the next period, consensus calls for EPS of -$1.25 on revenue of $187,500.00.
Next report — what to expect
Korro Bio, Inc. (KRRO) reports on November 11, 2026. Wall Street is expecting EPS of -$1.262 on revenue of $187,500.00. For trailing context, revenue declined -100.0% year over year last quarter. KRRO has beaten EPS in 5 of its 8 most recent quarters.
About Korro Bio, Inc.
Korro Bio, Inc. is a NASDAQ-listed Biotechnology company in the healthcare field that develops genetic therapeutics through RNA editing technology. The company is an early-stage biotech business rather than a commercial drug manufacturer, and its programs are aimed at both uncommon diseases and more widespread disorders.
Today's Snapshot
KRRO closed 0.6% below yesterday's close, in line with a weaker sector. Korro Bio reported early test data for KRRO-111, an inherited liver-disease treatment.
Trading Volume
Below 10d avg (236.8K)
216K
vs S&P 500 Today
Inline with Market
-0.06%
Updated: October 23, 2026 at 20:09 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$10.17 - $12.29Buy
- RSI (14)61.69Neutral
- Stochastic %K (14, 3, 3)75.11Neutral
- MACD Level (12, 26)-0.17Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.